APA (7th ed.) Citation

B, H., G, M., M, R., C, S., D, T., & M, M. (2025). Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders. Frontiers in drug delivery, 5, 1730142. https://doi.org/10.3389/fddev.2025.1730142

Chicago Style (17th ed.) Citation

B, Horn, Mambrini G, Roden M, Schaefer C, Thye D, and Magnani M. "Use of Encapsulated Dexamethasone Sodium Phosphate (eDSP) in Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Inflammatory Bowel Disorders." Frontiers in Drug Delivery 5 (2025): 1730142. https://doi.org/10.3389/fddev.2025.1730142.

MLA (9th ed.) Citation

B, Horn, et al. "Use of Encapsulated Dexamethasone Sodium Phosphate (eDSP) in Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Inflammatory Bowel Disorders." Frontiers in Drug Delivery, vol. 5, 2025, p. 1730142, https://doi.org/10.3389/fddev.2025.1730142.